Xiangxiang Zhou

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 13

Top Topics

Top Venues

Cell death discovery

Journal of hematology & oncology

Therapeutic advances in medical oncology

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shunfeng Hu, Tiange Lu, Juanjuan Shang, Yiqing Cai, Mengfei Ding, Xiangxiang Zhou, Xin Wang
PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations. Cell death discovery 9 (1) (2023)
Shunfeng Hu, Tiange Lu, Juanjuan Shang, Yiqing Cai, Mengfei Ding, Xiangxiang Zhou, Xin Wang
PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations. Cell death discovery 9 (1) (2023)
Shunfeng Hu, Tiange Lu, Juanjuan Shang, Yiqing Cai, Mengfei Ding, Xiangxiang Zhou, Xin Wang
PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations. Cell death discovery 9 (1) (2023)
Yiqing Cai, Liemei Lv, Tiange Lu, Mengfei Ding, Zhuoya Yu, Xiaomin Chen, Xiangxiang Zhou, Xin Wang
α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis. Cell death discovery 9 (1) (2023)
Yujia Zhai, Xiangxiang Zhou, Xin Wang
Novel insights into the biomarkers and therapies for primary central nervous system lymphoma. Therapeutic advances in medical oncology 14 (2022)
Tan Sang, Juan Yang, Jiarui Liu, Yang Han, Ying Li, Xiangxiang Zhou, Xin Wang
AMOT suppresses tumor progression via regulating DNA damage response signaling in diffuse large B-cell lymphoma. Cancer gene therapy 28 (10-11) (2021)
Yi Zhao, Juan Yang, Jiarui Liu, Yiqing Cai, Yang Han, Shunfeng Hu, Shuai Ren, Xiangxiang Zhou, Xin Wang
Inhibition of Polo-like kinase 4 induces mitotic defects and DNA damage in diffuse large B-cell lymphoma. Cell death & disease 12 (7) (2021)
Tiange Lu, Lei Shi, Guanggang Shi, Yiqing Cai, Shunfeng Hu, Jiarui Liu, Shuai Ren, Xiangxiang Zhou, Xin Wang
Derivation and validation of a lipid-covered prognostic model for mature T-cell lymphomas. Cancer cell international 21 (1) (2021)
Yingyue Liu, Xiangxiang Zhou, Xin Wang
Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities. Journal of hematology & oncology 14 (1) (2021)
Shunfeng Hu, Shuai Ren, Yiqing Cai, Jiarui Liu, Yang Han, Yi Zhao, Juan Yang, Xiangxiang Zhou, Xin Wang
Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling. Cell death and differentiation (2021)
Yurou Chu, Xiangxiang Zhou, Xin Wang
Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress. Journal of hematology & oncology 14 (1) (2021)
Yiqing Cai, Rui Feng, Tiange Lu, Xiaomin Chen, Xiangxiang Zhou, Xin Wang
Novel insights into the m6A-RNA methyltransferase METTL3 in cancer. Biomarker research 9 (1) (2021)
Xiangxiang Zhou, Linquan Zhan, Kai Huang, Xin Wang
The functions and clinical significance of circRNAs in hematological malignancies. Journal of hematology & oncology 13 (1) (2020)